Therapeutic approaches to mitigate the severe acute lung injury associated with severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection have rapidly entered …

The SARS-CoV-2 pandemic has already infected in excess of 50 million people worldwide
and resulted in 1.2 million deaths. While the majority of those infected will not have long …

The COVID-19 pandemic has challenged and, in many cases, exceeded the capacity of
hospitals and intensive care units (ICUs) worldwide. Health-care workers have continued to …

Disclaimer: This is an updated guideline from the Extracorporeal Life Support Organization
(ELSO) for the role of extracorporeal membrane oxygenation (ECMO) for patients with …

Background Lung transplantation is a life-saving treatment for patients with end-stage lung
disease; however, it is infrequently considered for patients with acute respiratory distress …

The coronavirus disease 2019 (COVID-19) pandemic caused by the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) exploded onto the world stage in early …

Several respiratory viruses are known to cause acute respiratory distress syndrome (ARDS).
Survival and lung recovery rates are well known for influenza viruses; however, ARDS …

Abstract The coronavirus disease 2019 (COVID-19) pandemic has had a major global
impact on solid organ transplantation (SOT). An estimated 16% global reduction in …

Transplantation of solid organs from donors with active SARS-CoV-2 infection has been
advised against due to the possibility of disease transmission to the recipient. However, with …

Background The COVID-19 pandemic has highlighted the need for rapid, cost effective and
easy-to-use diagnostic tools for SARS-CoV-2 infections that can be used in point of care …